Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LCI
2626
CALL
DELISTED
Lannett Company, Inc.
LCI
| $3.61M | ﹤0.01% |
33,925
-12,150
| -26% | -$1.48M |
|
|
HCR
2627
PUT
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $3.6M | ﹤0.01% |
234,800
+36,700
| +19% | +$496K |
|
2628
CALL
Shutterstock
SSTK
$203M
| $3.6M | ﹤0.01% |
56,500
-18,000
| -24% | -$1.03M |
|
|
BEAV
2629
DELISTED
B/E Aerospace Inc
BEAV
| $3.6M | ﹤0.01% |
69,605
+18,631
| +37% | +$901K |
|
2630
PUT
Kilroy Realty
KRC
$4.27B
| $3.59M | ﹤0.01% |
51,800
-1,000
| -2% | -$70.4K |
|
|
DGL
2631
DELISTED
Invesco DB Gold Fund
DGL
| $3.59M | ﹤0.01% |
84,344
+67,400
| +398% | +$2.92M |
|
2632
PUT
Interactive Brokers
IBKR
$43.7B
| $3.59M | ﹤0.01% |
407,200
-172,800
| -30% | -$1.53M |
|
2633
Cemex
CX
$15.8B
| $3.59M | ﹤0.01% |
470,116
+216,156
| +85% | +$1.59M |
|
2634
Tronox
TROX
$877M
| $3.59M | ﹤0.01% |
382,918
| – | – |
|
|
ZNGA
2635
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $3.58M | ﹤0.01% |
1,231,600
-491,700
| -29% | -$1.37M |
|
2636
PUT
Groupon
GRPN
$792M
| $3.58M | ﹤0.01% |
34,705
+15,135
| +77% | +$1.48M |
|
2637
PUT
Pacific Biosciences
PACB
$482M
| $3.58M | ﹤0.01% |
399,000
-51,100
| -11% | -$427K |
|
2638
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.19B
| $3.57M | ﹤0.01% |
79,986
-54,819
| -41% | -$2.4M |
|
2639
CALL
NatWest
NWG
$73.3B
| $3.57M | ﹤0.01% |
712,121
+166,585
| +31% | +$889K |
|
2640
iShares Global Energy ETF
IXC
$2.79B
| $3.57M | ﹤0.01% |
108,494
-1,891
| -2% | -$60.7K |
|
|
VMRK
2641
CALL
Vivmark Residential
VMRK
$26.1B
| $3.56M | ﹤0.01% |
55,400
-37,700
| -40% | -$2.51M |
|
|
TCP
2642
CALL
DELISTED
TC Pipelines LP
TCP
| $3.56M | ﹤0.01% |
62,500
-19,700
| -24% | -$1.07M |
|
2643
PUT
B&G Foods
BGS
$282M
| $3.56M | ﹤0.01% |
72,400
+30,500
| +73% | +$1.47M |
|
2644
CALL
Macerich
MAC
$6.78B
| $3.56M | ﹤0.01% |
44,000
-40,800
| -48% | -$3.45M |
|
2645
PUT
ATI
ATI
$29.2B
| $3.55M | ﹤0.01% |
196,600
+37,700
| +24% | +$625K |
|
|
RAX
2646
DELISTED
Rackspace Hosting Inc
RAX
| $3.55M | ﹤0.01% |
+112,120
| New | +$3.1M |
|
2647
PUT
American Eagle Outfitters
AEO
$2.8B
| $3.55M | ﹤0.01% |
198,800
+80,300
| +68% | +$1.44M |
|
|
APOL
2648
DELISTED
Apollo Education Group Inc Class A
APOL
| $3.55M | ﹤0.01% |
446,648
+120,586
| +37% | +$1.05M |
|
2649
American Tower
AMT
$81.2B
| $3.55M | ﹤0.01% |
31,300
-1,885
| -6% | -$215K |
|
|
BPL
2650
DELISTED
Buckeye Partners, L.P.
BPL
| $3.55M | ﹤0.01% |
+49,535
| New | +$3.52M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.